FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Bijlani Jeewat 		2. Issuer Name and Ticker or Trading Symbol

QUAKER CHEMICAL CORP [ KWR ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                      _____ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
SVP - Managing Director, Ams.
(Last)          (First)          (Middle)

QUAKER CHEMICAL CORPORATION, ONE QUAKER PARK, 901 E. HECTOR STREET 		3. Date of Earliest Transaction (MM/DD/YYYY)

8/15/2019
(Street)

CONSHOHOCKEN, PA 19428-2380
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

8/19/2019 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option (right to buy)   $154.92   (1) 8/15/2019     A      2421         (2) 2/26/2025   Common Stock   2421   $0.00   2421   D    
Employee Stock Option (right to buy)   $154.92   (1) 8/15/2019     A      2526         (3) 2/25/2026   Common Stock   2526   $0.00   2526   D    

Explanation of Responses:
(1)  The exercise price of the employee stock option was inadvertently omitted on the reporting person's original Form 4.
(2)  This award represents time-based restricted stock and stock options granted to the reporting person for the 2018-2020 Performance Period under the Company's 2016 Long-Term Performance Incentive Plan. The restricted stock vests on February 26, 2021 and the stock options are exercisable in three installments: 807 shares at grant; 807 shares on February 26, 2020; and 807 shares on February 26, 2021.
(3)  This award represents time-based restricted stock and stock options granted to reporting person for the 2019-2021 Performance Period under the Company's 2016 Long-Term Performance Incentive Plan. The restricted stock vests on February 25, 2022 and the stock options are exercisable in three consecutive annual installments: 842 shares on February 25, 2020; 842 shares on February 25, 2021; and 842 shares on February 25, 2022.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Bijlani Jeewat
QUAKER CHEMICAL CORPORATION
ONE QUAKER PARK, 901 E. HECTOR STREET
CONSHOHOCKEN, PA 19428-2380

SVP - Managing Director, Ams.

Signatures
Victoria K. Gehris, Attorney-in-Fact for Jeewat Bijlani 8/19/2019
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Quaker Houghton (NYSE:KWR)
Historical Stock Chart
From Oct 2024 to Nov 2024 Click Here for more Quaker Houghton Charts.
Quaker Houghton (NYSE:KWR)
Historical Stock Chart
From Nov 2023 to Nov 2024 Click Here for more Quaker Houghton Charts.